Meanwhile, the prevalence of CYP2C19*2 and CYP2C19*3 is as high as 36.6% in Chinese patients with coronary heart disease, and studies on these polymorphisms associated with bleeding events among patients with ACS in China are limited [15]. The gene discussed is CYP2C19; the disease is coronary artery disorder.